A Phase 3 Trial of Inebilizumab in Generalized Myasthenia GravisNEJM 392:2309-2320, Nowak,R.J.,et al, 2025
Myasthenia Gravis - Redemption for B-Cell DepletionNEJM 392:2382-2384, Wolfe,G.I. & Shelly,S., 2025